Intangible assets

The carrying amount of intangible assets mainly comprises goodwill on the acquisition of NeoResins in 2005 (€358 million), Crina in 2006 (€9 million) and Pentapharm in 2007 (€36 million). For further information on these assets including the discussion of the related impairment tests, please refer to Note 8 'Intangible assets' in the 'Notes to the consolidated financial statements of Royal DSM'.

 
Goodwill
Under construction
Other
Total
     
Balance at 1 January 2015
    
Cost
398
11
61
470
Amortization and impairment losses
-
-
26
26
     
Carrying amount
398
11
35
444
     
Change in carrying amount
    
- Capital expenditure
-
7
-
7
- Put into operation
-
(1)
1
-
- Amortization
-
-
(6)
(6)
- Exchanged differences
5
-
-
5
- Other reclassifications
-
-
1
1
     
 
5
6
(4)
7
Balance at 31 December 2015
    
Cost
403
17
62
482
Amortization and impairment losses
-
-
32
32
     
Carrying amount
403
17
30
450
     
Change in carrying amount
    
- Capital expenditure
-
3
-
3
- Put into operation
-
(16)
16
-
- Amortization
-
-
(6)
(6)
     
 
-
(13)
10
(3)
Balance at 31 December 2016
    
Cost
403
4
78
485
Amortization and impairment losses
-
-
38
38
     
Carrying amount
403
4
40
447